OpenAI Acquires drug R&D collaboration platform Orchestra Bio
PANews, citing OpenAI an official announcement, said that OpenAI has acquired the drug R&D collaboration platform Orchestra Bio, and plans to integrate its team and technology into the life sciences AI model and tool, Rosalind.